Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.
Use of multiple sclerosis drugs among pregnant individuals with live-birth deliveries in the FDA's Sentinel Distributed Database.
Immunomodulatory Nanocarriers in Multiple Sclerosis: Dual Targeting of Microglia and Mitochondria for Precision Neurotherapy.
Explainable Multitask Transformers for Early Detection of Smoking Behaviors and Lung Cancer Symptoms from Danish Electronic Health Records.
Pediatric osmotic demyelination syndrome triggered by post-traumatic pituitary stalk injury: a case report.
Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting.
Autoimmune nodopathy associated with contactin-2 antibodies manifesting as Guillain-Barré syndrome: a case report.
Triple antibody-associated autoimmune encephalitis overlap: a case report of co-existing MOG-IgG, anti-NMDAR, and anti-mGluR5 positivity.
A new HANDling of progressive MS and progressive MS trials.
Chronic inflammatory demyelinating polyneuropathy with painful ophthalmoplegia: a case report.
Integrated Blood Inflammatory Ratios and Cerebrospinal Fluid Blood‒Brain Barrier Dysfunction Predict Relapse Risk in Neuromyelitis Optica Spectrum Disorder.
PIM1-induced Drp1 phosphorylation disrupts microglial mitophagy and aggravates neuroinflammation.
Acute Spinal Cord Infarct Secondary to Fibrocartilaginous Embolism Treated With Tenecteplase.
Discontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control study.
Spatiotemporal profiling of white matter lesions and their contribution in the pathologies of Parkinson's disease animal models.
Spinal cord microglia exhibit a dysfunctional response to myelin damage.
Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.
Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosis.
Quantitative MRI metrics associated with lesion evolution in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.
Reconstructing regenerative niches in the central nervous system: Molecular and microenvironmental determinants of axonal regeneration.
Lead (Pb) exposure results in cell type specific changes in the mouse retina and optic nerve.
Factors Influencing Early and Late B-Cell Repopulation After Rituximab Therapy in Pediatric Central Nervous System Inflammatory Disorders.
Synthesis strategies of gold nanoclusters and their application in anti-inflammatory therapy.
UNEXPECTED MECHANISMS OF REPURPOSED DRUGS IN THE PATHOGENIC PATHWAYS OF NEURODEGENERATIVE DISEASES. DISCOVERING NEW NEUROPROTECTIVE THERAPIES IN CELLULAR MODELS.

Pages